Disopyramide and Buprenorphine: Interaction Details

Brand names
Buprenorphine
ButransBelbucaSublocade +2 more
Disopyramide
NorpaceNorpace CR
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Buprenorphine

Brand names
  • Butrans
  • Belbuca
  • Sublocade
  • Buprenex
  • Brixadi

Disopyramide

Brand names
  • Norpace
  • Norpace CR

What Happens When You Take Disopyramide With Buprenorphine

What can happen when they are taken together (rated Major)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Buprenorphine should not be given together with medications that can lengthen the .123 Whether combining buprenorphine with other agents that prolong the QT interval carries risk has not been established. When deciding whether to prescribe buprenorphine for patients who have risk factors, including , , a recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, prolonged QT at baseline, subclinical long-QT syndrome, or severe , clinicians should take these observations into account.4

The Disopyramide and Buprenorphine Interaction, Explained

Both buprenorphine (used for pain or use disorder) and disopyramide (Norpace, used to keep the heartbeat steady) can affect the heart's electrical rhythm. Doctors measure part of that rhythm on an as the . Taking the two together could, in theory, stretch it out more than either drug alone, which in rare cases can lead to a dangerous irregular heartbeat.

This concern is based on how the drugs work, not on reports of harm from this exact pair. Please keep taking your medicines as prescribed. Your care team can check your heart rhythm and lab values and decide what is safest for you.

Mechanism: . Disopyramide is a class Ia antiarrhythmic with known QT-prolonging and torsadogenic potential. Buprenorphine has been associated with QTc prolongation (dose-related, notably with transdermal and higher-dose formulations). No PK interaction is implied.

  • Severity: Major. Evidence: Theoretical. The risk of this specific combination has not been quantified. Onset: Unspecified.
  • Management: Labeling advises avoiding buprenorphine with QT-prolonging drugs. If is judged necessary, weigh the risk factors: , , , recent conversion from AF, HF, digitalis therapy, baseline QT prolongation, or congenital/subclinical long QT. Consider a baseline with follow-up, plus K+/Mg2+ monitoring.

See the 4 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Disopyramide and Buprenorphine Interact

The likely mechanism


In short: Disopyramide and buprenorphine both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Disopyramide and Buprenorphine Interaction

The prescribing guidance for buprenorphine recommends avoiding it with medicines that can lengthen the , and disopyramide is one of them. Your care team may:

  • Consider whether a different option fits your needs better
  • Look for added risk factors, such as low potassium or magnesium, a slow heart rate, heart failure, digoxin use, or a known long QT
  • Monitor you more closely if both medicines are needed

What you can do: Keep taking both medicines as prescribed. Tell your pharmacist or doctor about every medicine you use. Get help right away if you have fainting, a racing or pounding heartbeat, or sudden dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Disopyramide or Buprenorphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Disopyramide and Buprenorphine: Common Questions

How serious is the Disopyramide and Buprenorphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Disopyramide and Buprenorphine interaction managed?

The prescribing guidance for buprenorphine recommends avoiding it with medicines that can lengthen the , and disopyramide is one of them. Your care team may: Consider whether a different option fits your needs better Look for added risk factors, such as low potassium or magnesium, a slow heart rate, heart failure, digoxin use, or a known long QT Monitor you more closely if both medicine… Management is individual — always follow your own care team's guidance.

Who is at higher risk from the Disopyramide and Buprenorphine interaction?

The interaction record names these groups as more likely to be affected:

  • People with low potassium or magnesium
  • People with heart disease or heart failure

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Disopyramide and Buprenorphine Interaction

Ask in your own words about taking Disopyramide and Buprenorphine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (4)

  1. Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
  2. Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
  3. Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
  4. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Disopyramide and Buprenorphine

Also serious with Buprenorphine

Also serious with Disopyramide

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Buprenorphine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.